###begin article-title 0
###xml 59 75 57 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 59 75 <span type="species:ncbi:562">Escherichia coli</span>
2'-Deoxyribonolactone lesion produces G-->A transitions in Escherichia coli
###end article-title 0
###begin p 1
###xml 93 106 93 106 <email xmlns:xlink="http://www.w3.org/1999/xlink">smurat@igr.fr</email>
To whom correspondence should be addressed. Tel: +33 1 42115404; Fax: +33 1 42115276; Email: smurat@igr.fr
###end p 1
###begin p 2
###xml 113 151 113 151 <email xmlns:xlink="http://www.w3.org/1999/xlink">jean-francois.constant@ujf-grenoble.fr</email>
Correspondence may also be addressed to Jean-Francois Constant. Tel: +33 4 76514433; Fax: +33 47651 4649; Email: jean-francois.constant@ujf-grenoble.fr
###end p 2
###begin p 3
###xml 490 506 486 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 754 760 746 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 814 816 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 980 987 972 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1078 1084 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1182 1189 1174 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xth nfo</italic>
###xml 1304 1311 1296 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 490 506 <span type="species:ncbi:562">Escherichia coli</span>
###xml 754 760 <span type="species:ncbi:562">E.coli</span>
###xml 1078 1084 <span type="species:ncbi:562">E.coli</span>
2'-Deoxyribonolactone (dL) is a C1'-oxidized abasic site damage generated by a radical attack on DNA. Numerous genotoxic agents have been shown to produce dL including UV and gamma-irradiation, ene-dye antibiotics etc. At present the biological consequences of dL present in DNA have been poorly documented, mainly due to the lack of method for introducing the lesion in oligonucleotides. We have recently designed a synthesis of dL which allowed investigation of the mutagenicity of dL in Escherichia coli by using a genetic reversion assay. The lesion was site-specifically incorporated in a double-stranded bacteriophage vector M13G*1, which detects single-base-pair substitutions at position 141 of the lacZalpha gene by a change in plaque color. In E.coli JM105 the dL-induced reversion frequency was 4.7 x 10-5, similar to that of the classic abasic site 2'-deoxyribose (dR). Here we report that a dL residue in a duplex DNA codes mainly for thymidine. The processing of dL in vivo was investigated by measuring lesion-induced mutation frequencies in DNA repair deficient E.coli strains. We showed a 32-fold increase in dL-induced reversion rate in AP endonuclease deficient (xth nfo) mutant compared with wild-type strain, indicating that the Xth and Nfo AP endonucleases participate in dL repair in vivo.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c1">1</xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c2">2</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c5">5</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c6">6</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c7">7</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c8">8</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c9">9</xref>
###xml 569 570 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c10">10</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c12">12</xref>
###xml 623 625 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c13">13</xref>
###xml 626 628 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c14">14</xref>
###xml 647 649 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c15">15</xref>
###xml 650 652 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c17">17</xref>
###xml 826 828 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c18">18</xref>
###xml 829 831 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c20">20</xref>
###xml 896 897 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c8">8</xref>
###xml 898 900 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c10">10</xref>
###xml 901 903 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c21">21</xref>
###xml 904 906 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c23">23</xref>
###xml 1605 1607 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c20">20</xref>
###xml 1608 1610 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c24">24</xref>
###xml 2097 2099 2086 2088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c25">25</xref>
###xml 2105 2113 2094 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2118 2125 2107 2114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2267 2269 2256 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c11">11</xref>
###xml 2270 2272 2259 2261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c15">15</xref>
###xml 2273 2275 2262 2264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c16">16</xref>
###xml 2276 2278 2265 2267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c26">26</xref>
###xml 2279 2281 2268 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c31">31</xref>
###xml 2436 2438 2425 2427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c19">19</xref>
###xml 2439 2441 2428 2430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c32">32</xref>
###xml 2442 2444 2431 2433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c34">34</xref>
###xml 2579 2581 2568 2570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c35">35</xref>
2'-Deoxyribonolactone (dL) is one of the numerous oxidation products formed in DNA. The lesion is produced following radical hydrogen atom abstraction at the 1' position of 2'-deoxyribose (1). This C1'-oxidized apurinic/apyrimidinic (AP) site has been reported to be produced through a variety of radical processes including the action of anticancer drugs [e. g. the neocarzinostatin chromophore which contains the enediyne residue (2-5)], heterocyclic N-oxides of the tirapazamine family (6,7), cationic manganese porphyrins (8,9), copper phenanthroline complex Cu(OP)2, a chemical nuclease (10-12), or gamma-irradiation (13,14) and UV exposure (15-17). One of the main features of this abasic lesion resides in its alkali-labile sensitivity: the lactone leads to DNA strand scission by beta and delta elimination processes (18-20) with formation of 5-methylene furanone as an ultimate product (8,10,21-23). For a long time this instability has been a limitation on knowledge of the chemistry and biological consequences of the lesion. To address the major questions concerning the specificity of its repair and its mutagenic potency, the disposal of short synthetic DNAs containing a single dL lesion is of prime importance. If very little is known about dL repair, it has been mainly due to the paucity of synthetic methods. In this context, our laboratory developed an efficient and general synthesis of oligodeoxyribonucleotides containing a dL lesion at a predetermined position in the sequence. This method is based on the use of a 7-nitroindole nucleotide (dNi) as a photo-active precursor of dL (20,24). The modified nucleoside dNi has a maximum absorption at 360 nm and illumination above 320 nm triggers a radical process where an intramolecular 1'-hydrogen abstraction is performed by the nitroindole moiety in its excited state, evolving quantitatively towards dL formation. It should be stressed that irradiation of DNA above 320 nm does not generate photodamage. Such a quantitative triggered method allows the production of oligonucleotide quantities for structural determination (25) and in vitro and in vivo biological studies. Other methods based on the photo-triggered formation of the dL lesion in short oligonucleotides have also been reported (11,15,16,26-31). Despite their lower selectivity and poorer yields, these methods enabled investigations on dL reactivity towards itself and certain DNA repair enzymes (19,32-34). Recently, a new approach based on the photoactivation of a nitroveratryl cyanohydrine motif to generate dL has also been described (35).
###end p 5
###begin p 6
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c36">36</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c37">37</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c38">38</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c39">39</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c40">40</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c43">43</xref>
###xml 778 794 778 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 893 895 893 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c44">44</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c45">45</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c46">46</xref>
###xml 1110 1118 1110 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1123 1130 1123 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1162 1168 1162 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c47">47</xref>
###xml 1395 1397 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c48">48</xref>
###xml 1569 1571 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c49">49</xref>
###xml 1637 1639 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c50">50</xref>
###xml 1709 1717 1709 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1767 1768 1767 1768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 1770 1772 1770 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c51">51</xref>
###xml 1801 1803 1801 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c32">32</xref>
###xml 1899 1905 1899 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1911 1913 1911 1913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c33">33</xref>
###xml 1959 1961 1959 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c34">34</xref>
###xml 778 794 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1162 1168 <span type="species:ncbi:562">E.coli</span>
###xml 1624 1629 <span type="species:ncbi:9606">human</span>
###xml 1869 1874 <span type="species:ncbi:9606">human</span>
###xml 1899 1905 <span type="species:ncbi:562">E.coli</span>
###xml 1924 1929 <span type="species:ncbi:9606">human</span>
Our starting hypothesis in this study is based on the structural analogy between dL and 2'-deoxyribose, a regular abasic site, which suggests that the AP site-specific repair enzymes might be involved in dL repair. The AP site is an intermediate of the base excision repair (BER) pathway in which DNA glycosylases excise mispaired and/or modified bases (36,37). The AP site lacks a base and is potentially cytotoxic and/or mutagenic (38,39). This non-informative lesion can lead to nucleotide misincorporation during the replication and transcription processes (40-43). During processing of the abasic lesions by the BER pathway, the initial step involves AP endonucleases, which incise DNA at the 5' position adjacent to the baseless site. Two major enzymes were identified in Escherichia coli: exonuclease III (Xth), which represents >80% of the total AP endonuclease activity in wild type (WT) (44), and endonuclease IV (Nfo), which accounts for 5-10% of the total AP-endonuclease activity (45,46). If the baseless lesion is refractory to excision repair, it may be encountered by DNA polymerases. Numerous in vitro and in vivo studies of baseless lesions in E.coli came up with the establishment of an 'A rule': when a DNA polymerase is confronted with a non-instructional lesion, it tends to insert the dAMP nucleotide opposite the lesion rather than any of the three other nucleotides (47,48). Nevertheless, this 'A rule' is not always strictly obeyed. For example, in mammalian cells, a random incorporation of nucleotide opposite 2'-deoxyribose has been found (49), whereas a dAMP was preferentially incorporated in human cells (50). In a previous study we have shown that the 'A rule' was obeyed for in vitro dL translesional synthesis by Klenow fragment exo- (51). Greenberg and colleagues (32) found that DNA substrates containing a dL lesion are cleaved by human Ape1 and can react with E.coli Nth (33), Fpg and human Nei-like protein 1 (hNEIL1) (34) to form DNA.protein covalent cross-links.
###end p 6
###begin p 7
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 131 137 <span type="species:ncbi:562">E.coli</span>
In the present study, we extended dL repair to a prokaryotic in vivo system using a bacteriophage-based genetic reversion assay in E.coli. Mutation frequencies and repair pathways for dL and its precursor 7-nitroindole (Ni) were determined and compared with those for 2'-deoxyribose (dR).
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 28 34 <span type="species:ncbi:562">E.coli</span>
Microbiological methods and E.coli strains
###end title 9
###begin p 10
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c52">52</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c53">53</xref>
###xml 392 398 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 435 437 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c54">54</xref>
###xml 518 520 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c53">53</xref>
###xml 119 144 <span type="species:ncbi:12420">filamentous bacteriophage</span>
###xml 392 398 <span type="species:ncbi:562">E.coli</span>
All bacterial genetic procedures were performed as described (52,53); these included manipulation with single-stranded filamentous bacteriophage vectors. Rich medium was LB broth, supplemented when required with 100 microg/ml ampicillin or 50 microg/ml kanamycin or 20 microg/ml chloramphenicol or 10 microg/ml tetracycline. M9 minimal medium was supplemented with thiamine. Electrocompetent E.coli strains were prepared as described (54). Fresh SOC medium was used as the incubation buffer following electroporation (53).
###end p 10
###begin p 11
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb1">1</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c55">55</xref>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c56">56</xref>
###xml 1051 1053 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c57">57</xref>
###xml 1140 1141 1121 1122 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1197 1198 1175 1176 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1223 1229 1201 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1353 1355 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c53">53</xref>
###xml 4 10 <span type="species:ncbi:562">E.coli</span>
###xml 295 301 <span type="species:ncbi:562">E.coli</span>
###xml 1223 1229 <span type="species:ncbi:562">E.coli</span>
The E.coli strains and the plasmid used in this study are listed in Table 1. AB1157 derivatives containing the Tn10 insertions at specific sites in the genome were constructed by P1 transductions of the tetracycline resistance marker from the collection of strains for genetic mapping (55). The E.coli strains BH70F', BH110F' and BH160F' were obtained by direct electrotransfer of plasmid pCJ105 (Cmr) from CJ236 to BH70, BH110 and BH160 strains as described (56). The transformants were selected on media containing two antibiotics: either kanamycin (10 microg/ml) + chloramphenicol (10 microg/ml) or tetracycline (5 microg/ml) + chloramphenicol (10 microg/ml). Phenotypes of all strains were verified on antibiotic selective media and by their ability to propagate the M13 bacteriophage. In addition, the phenotype of the BH110F' strain was verified by plating on LB media containing methyl methanesulfonate at various concentrations (2-20 mM). Double-stranded M13G*1 DNA was a gift from Dr Lawrence A. Loeb (University of Washington, Seattle, WA) (57). Individual dark blue plaques were subcloned on top agar 1% containing ispropyl-beta-d-thiogalactopyranoside, 5-bromo 4-chloro 3-indolyl beta-d-galactoside (X-gal) and E.coli JM105 cells. An isolated dark blue plaque was grown in 3 ml LB for 12 h and single-stranded DNA was purified as described (53). The purity of the single-stranded DNA was verified by agarose gel electrophoresis.
###end p 11
###begin title 12
Enzymes
###end title 12
###begin p 13
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 20 26 <span type="species:ncbi:562">E.coli</span>
Purification of the E.coli Nfo (endonuclease IV) and UNG (uracil-DNA glycosylase) were performed as described (46,58). Molecular biology products, restriction endonucleases and T4 DNA ligase were purchased from Roche Diagnostics (Meylan, France). T4 polynucleotide kinase was purchased from New England BioLabs (OZYME, Saint-Quentin en Yvelines, France).
###end p 13
###begin title 14
Oligonucleotides
###end title 14
###begin p 15
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c24">24</xref>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f1">1</xref>
###xml 271 272 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 290 291 290 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X</bold>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c53">53</xref>
Nitroindole nucleoside phosphoramidite was synthesized according to the method described (24). The structures of 2'-deoxyribonitroindole abasic site precursor, 2'-deoxyribonolactone and 2'-deoxyribose are illustrated in Figure 1. Phosphorylated 41mer oligonucleotide d(PO3-CTATTA CGCCAGCTGGXAAATGGGGGATGTGCTGCAAGGCG) complementary to positions 117-157 of the lacZ sequence, where X is 2'-deoxycytidine (dC) or 2'-deoxyguanosine (dG) or 2'-deoxyribonitroindole (dNi) or 2'-deoxyuridine (dU), were synthesized by the standard phosphoramidite method with a DNA synthesizer (Perceptive Biosystem 8900 DNA). Oligonucleotides were separated by denaturing 20% polyacrylamide gel electrophoresis (PAGE) and purified by elution from C18 column with a water-acetonitrile mixture (7/3) as described (53).
###end p 15
###begin title 16
Construction of site-specifically modified double-stranded M13G*1
###end title 16
###begin p 17
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c59">59</xref>
###xml 346 347 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2193 2194 2123 2124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2585 2587 2511 2513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 2981 2987 2891 2897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 3025 3027 2935 2937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c54">54</xref>
###xml 2981 2987 <span type="species:ncbi:562">E.coli</span>
Construction of double-stranded M13G*1 vectors with site-specifically incorporated lesion precursors (dU or dNi) were performed as described (59). Briefly, 10 pmol of the synthetic 5' phosphorylated 41mer oligonucleotide was hybridized to 0.2 microg single-stranded circular M13G*1 at a 25:1 primer-to-template ratio in 20 mM Tris-HCl, 10 mM MgCl2, 50 mM NaCl pH 7.5 buffer in a final volume of 10 microl. The solution was heated at 90degreesC for 3 min and then allowed to cool to 30degreesC before storage in an ice-water bath. The synthesis of the second strand was carried out by adding to the annealing reaction 3 U of T4 DNA polymerase, 3 U of T4 DNA ligase and 3 microl of 10x synthesis buffer containing 5 mM of each dNTP, 10 mM ATP, 100 mM Tris-HCl pH 7.5 and 20 mM dithiothreitol. The synthesis reaction was incubated in an ice bath for 5 min, then at 25degreesC for 5 min and finally at 37degreesC for 90 min. The reaction was stopped by adding 90 microl of TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) at 4degreesC. The reaction products were analyzed on a 0.8% agarose gel containing 3 microg/ml ethidium bromide in TAE (40 mM Tris-acetate and 1 mM EDTA). The double-stranded DNA was desalted using a Sephadex G50 column (volume 1 ml). Aliquots (1-2 microl) of the desalted phage DNA were used directly for transformation. The blue revertant plaques were screened on media containing X-gal (40 microg/ml) and the nucleotide sequences of the phage DNA from the blue plaques were determined. A sample of M13G*1 containing a single dR residue was prepared by treating 20 ng of double-stranded circular M13G*1 containing a 2'-deoxyuridine at position141 with 1 nM of the UNG protein at 37degreesC for 60 min. The M13G*1 containing dL residue was prepared by illuminating the vector containing the nitroindole residue (dNi) at 365 nm for 14 h at 4degreesC. The illumination device used in this study was obtained from Fisher Bioblock Scientific (Fisher Scientific SAS, Elancourt Cedex, France) and consisted of an illumination tube and a filter that selected wavelengths ranging from 310 to 400 nm centered at 365 nm (the maximum absorption for dNi is 360 nm) with an energy of 7 mW/cm2. The illumination tube is guaranteed to be free from lower wavelengths (particularly 254 nm); under such conditions the main absorbing compound is the Ni residue, and DNA damage which requires more energetic radiations (260 nm for creating thymine dimers and <200 nm for generating reactive oxygen species) are excluded. The conversions dU-->dR and dNi-->dL was controlled by annealing the 32P-labeled modified primers with their complementary strand and treating the short duplexes with either 0.1 M NaOH at 37degreesC for 30 min or 100 nM Nfo at 37degreesC for 10 min. The alkali labile lesions and abasic site residues were then evidenced by denaturing PAGE. A sample of 10 ng of the lesion containing double-stranded M13G*1 phage was used to electroporate a 55 microl suspension of E.coli electrocompetent cells as described (54). Transformation mixtures were incubated in 900 microl of SOC medium at 37degreesC for 1 h followed by overnight incubation in 10 ml LB at 37degreesC. The double-stranded phage DNA was isolated using a Nucleospin-plasmid column (Macherey Nagel S.ar.l., Hoerdt, France). The presence and purity of M13G*1 DNA was controlled by agarose gel electrophoresis (0.8%, TAE buffer).
###end p 17
###begin title 18
Lesion-induced reversion rate assay
###end title 18
###begin p 19
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 220 222 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11</sup>
###xml 306 312 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 36 42 <span type="species:ncbi:562">E.coli</span>
###xml 306 312 <span type="species:ncbi:562">E.coli</span>
Various strains of electrocompetent E.coli were transformed with double-stranded M13G*1 containing dR or dL or dNi followed by overnight incubation at 37degreesC with shaking. The centrifuged cultures containing about 1011 phage particles per millilitre were used for plating on media containing X-gal and E.coli JM105. After overnight incubation at 37degreesC, the dark blue plaques representing revertants were scored. Mutation frequency was calculated as the ratio of dark blue plaques to the total number of plaques. Three independent synthesis reactions were performed and five to seven independent transformations were carried out to determine mutation frequencies. The nucleotide sequence of the phage DNA from revertants was determined by dideoxy DNA sequencing using a Big-Dye terminator V3.1 cycle sequencing kit (ABI Applied Biosystems, France) according to the manufacturer's instructions. Sequence reading was performed on a 3100 ABI Sequencor.
###end p 19
###begin title 20
Altered restriction site mutagenesis
###end title 20
###begin p 21
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 40 46 40 46 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATC<bold>T</bold></underline>
A 5' phosphorylated primer d(CACAAACGAATGGATCT TCATTAAAGCCAGAATGC) containing a mutated BamHI restriction site (C replaced by T in bold type) and the primer containing dNi residue were co-hybridized with single-stranded M13G*1 phage. Primer elongation, vector ligation, precursor conversion, cell transformation, growth and phage DNA recovery were performed as described above. A resulting 5 microg of the double-stranded M13G*1 phage DNA progeny was incubated overnight at 37degreesC with 40 U of BamHI in the reaction buffer supplied by manufacturer and purified by ethanol precipitation. The BamHI-digested phage DNA was used to determine the mutation frequency.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
Site-specific incorporation of dNi, dL and dR into M13G*1
###end title 23
###begin p 24
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 467 469 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c57">57</xref>
###xml 1065 1066 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f2">2</xref>
###xml 1208 1209 1200 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f2">2</xref>
###xml 1347 1348 1339 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f2">2</xref>
###xml 1359 1361 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c60">60</xref>
###xml 1470 1471 1462 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f2">2</xref>
###xml 1660 1661 1652 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh622f2">2</xref>
###xml 63 69 <span type="species:ncbi:562">E.coli</span>
We have designed a strategy allowing the introduction of dL in E.coli cells to study its mutagenic effect and its repair in vivo. The assay combines the use of a lesion precursor and the previously described bacteriophage-based genetic reversion assay. A bacteriophage vector M13G*1 detects single-base substitutions, namely X-->C, T and A (where X is either a G or a modified residue) at position 141 of the lacZalpha gene by change from white-to-blue plaque color (57). To generate site-specifically modified circular duplex DNA containing G.C, C.C U.C and Ni.C base pairs at position 141, the 41mer oligonucleotides complementary to the 117-157 region of the single-stranded M13G*1, containing dG, dC, dU and dNi, respectively, were used as primers. About 90% of the 41mer primers were fully extended in the presence of T4 DNA polymerase, T4 DNA ligase and the dNTPs (data not shown). Alkaline and Nfo treatments were used to ascertain conversion of the dU and dNi precursors into dR and dL after UNG treatment and illumination, respectively. As shown in Figure 2, >/=95% of the dU- and dNi-containing oligonucleotide duplexes were resistant to the treatment, indicating the absence of abasic sites (Fig. 2, lanes 1, 6 and 7). Partial degradation of the dNi-oligonucleotide by excess Nfo is due to non-specific 3'-5' exonuclease activity (Fig. 2, lane 6) (60). As expected, UNG-treated and UV-irradiated duplex oligonucleotides were cleaved by alkaline and Nfo (Fig. 2, lanes 3, 4, 9 and 10), indicating efficient formation of the abasic site residues. However, <8-10% of the non-converted dNi precursor remains under the illumination conditions used (Fig. 2, lanes 9 and 10), and approximately4-6% of dL undergoes spontaneous degradation by beta and delta elimination (lane 8). The illumination and UNG treatment did not degrade the phage DNA and did not affect transformation efficiency (data not shown).
###end p 24
###begin title 25
###xml 55 57 55 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 69 75 <span type="species:ncbi:562">E.coli</span>
Analysis of the lesion-induced mutation frequencies in WT and mutant E.coli
###end title 25
###begin p 26
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 311 313 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 742 748 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 886 894 880 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1018 1019 1012 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb2">2</xref>
###xml 1020 1021 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb4">4</xref>
###xml 1144 1146 1138 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 1157 1159 1151 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 1163 1172 1157 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT E.coli</italic>
###xml 742 748 <span type="species:ncbi:562">E.coli</span>
###xml 1166 1172 <span type="species:ncbi:562">E.coli</span>
A sufficient number of transformants (105-108 per microgram of DNA) to measure mutation frequency were obtained with the double-stranded phage M13G*1 containing dC.dC, dG.dC, dR.dC, dNi.dC and dL.dC nucleotide pairs. As expected, M13G*1 containing dC.dC mismatch induced blue plaques with high frequency (4 x 10-1). The photochemical treatment may produce small amounts of undesirable DNA damage which in turn could contribute to mutagenesis. To address this possibility we irradiated the double-stranded M13G*1 vector containing a dG.dC base pair at position 141 under the same conditions as for the vector containing the dNi residue at 365 nm for 14 h at 4degreesC. The irradiated M13G*1 containing dG.dC produced only colorless plaques in E.coli JM105 and no blue plaques were found among 60 000 plaques screened. These results strongly indicate that the photochemical treatment and in vitro primer synthesis did not induce mutations at a detectable level under the experimental conditions used. As shown in Tables 2-4, the presence of dR, dNi and dL lesions in M13G*1 induced reversion to blue plaques with frequencies ranging from 2.2 x 10-5 to 14 x 10-5 in WT E.coli strains AB1157 and/or JM105 proficient in DNA repair.
###end p 26
###begin p 27
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c61">61</xref>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 727 729 725 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;4</sup>
###xml 789 791 785 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 382 388 <span type="species:ncbi:562">E.coli</span>
In the present study, we used altered site mutagenesis (61) to select the dL-containing strand progeny. Two oligonucleotides, one containing dNi and the other containing a mutated BamHI restriction site, were used as primers to generate double-stranded M13G*1. The resulting M13G*1 with mutated BamHI site and dNi was UV-irradiated and used for the first round of transformation to E.coli BH70F'. The phage DNA from the transformants was then digested by BamHI and used for the second round of transformation, and the reversion frequencies in phage progeny from the first and second rounds of transformation were compared. Only a 2-fold increase in mutation frequency was found for the BamHI-mutated progeny [(1.0 +/- 0.2) x 10-4] compared with the non-digested progeny [(5.5 +/- 5.6) x 10-5].
###end p 27
###begin p 28
###xml 132 134 132 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb2">2</xref>
###xml 455 457 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 587 589 587 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 763 765 763 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 322 328 <span type="species:ncbi:562">E.coli</span>
To investigate the contribution of different DNA repair pathways to the elimination of dL, the modified M13G*1 was transformed into WT (AB1157 and/or JM105), AP endonuclease deficient (BH110F'), DNA glycosylase deficient (BH160F'), nucleotide excision repair (NER) deficient (BH430F') and recombination deficient (BH1100) E.coli strains. As shown in Table 2, >30-fold higher mutation frequency was observed in BH110F' strain compared with isogenic BH70F' WT strain. Although a 5-fold higher mean mutation frequency was observed in BH160F' and BH1100 strains compared with the respective WT strains, the differences were not statistically significant (p > 0.05). No detectable increase in reversion rate was observed in the BH430 strain compared with the isogenic WT JM105 strain.
###end p 28
###begin p 29
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb3">3</xref>
###xml 266 268 266 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 72 78 <span type="species:ncbi:562">E.coli</span>
The mutation frequencies induced by dR and dNi lesions in WT and mutant E.coli strains were also measured and compared with that of dL. As shown in Table 3, the dR-induced mutation frequencies in BH110F', BH160F' and BH1100F' were only 3-5-fold higher than those in WT strains, suggesting that dR is less mutagenic than dL in these repair deficient strains. Similarly to dL, no increase in dR-induced reversion rates was detected in the NER-deficient strain.
###end p 29
###begin p 30
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb4">4</xref>
###xml 284 286 284 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 426 428 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
The synthetic precursor, the dNi nucleotide, is not a natural modification and it has been specially designed to generate dL in DNA under UV irradiation. As shown in Table 4, significant variation in dNi-induced mutation frequencies was detected between non-isogenic BH70F' and JM105 WT strains (p < 0.01), whereas no significant increase in mutation frequency was observed in BER-deficient mutants compared with the isogenic WT strain. In contrast, a >10-fold increase in reversion rate was observed in the homologous recombination-deficient strain. Surprisingly, there was a very low yield of transformants for dNi-containing phage DNA in the NER-deficient BH430 strain. The number of plaques did not allow determination of the reversion frequency for this mutant.
###end p 30
###begin title 31
Analysis of the mutation spectra induced by dL, dNi and dR
###end title 31
###begin p 32
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb5">5</xref>
###xml 642 644 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c62">62</xref>
###xml 645 647 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c63">63</xref>
The phage DNAs from revertants were sequenced in order to determine the nature and occurrence of mutations resulting from in vivo replication of modified vectors. As shown in Table 5, all mutations were detected at the target site and no other sequence changes were detected within a 200 nt region containing the target site. Since the M13G*1-based reversion assay was designed to detect all base substitutions, except X-->G base substitution and frameshifts, the majority of dL, dR and dNi-induced mutations were X-->A,C,T mutations. As expected, in 79% of the cases dAMP was introduced opposite to dR, confirming the previous observations (62,63). In contrast, the spectrum of mutations induced by dL and dNi did not obey the 'A rule'. For dL, TMP was the most frequently incorporated nucleotide (55%) followed by dAMP (18%) and dGMP (12%). A significant number (11%) of two-nucleotide inversions GX-->AG (where X is dL) were also observed. On the other hand, both TMP (40%) and dAMP (42%) were preferentially introduced opposite dNi. An inversion GX-->TG (3%) and insertion of an extra C accompanied with a T deletion (8%) were also detected for dNi. The difference in mutation spectra obtained for dL and dNi further confirms the photoconversion of dNi to dL within a phage vector.
###end p 32
###begin title 33
DISCUSSION
###end title 33
###begin p 34
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c64">64</xref>
###xml 535 537 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c20">20</xref>
###xml 580 585 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 588 590 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c57">57</xref>
Free-radical attack and oxidation produce a tremendous multiplicity of DNA modifications in vivo. Consequently, the toxicity and the mutagenic effect of a given lesion are difficult to assess. A variety of efficient and reliable methods have been developed for the construction of site-directed mutations in extra-chromosomal vector DNA using synthetic oligonucleotides with defined lesions in both prokaryotic and eukaryotic cells (64). To incorporate the very unstable dL lesion, which is 20 times less stable than dR at 37degreesC (20), we chose a strategy, described by Cheng et al. (57) for an unstable exocyclic guanine adduct, based on the site-directed incorporation of a lesion into the double-stranded M13mp2-derived bacteriophage vector M13G*1. This approach allows the incorporation of dNi and dU (the stable precursors of dL and dR, respectively) following conversion to the baseless lesions and immediate transformation into cells.
###end p 34
###begin p 35
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c32">32</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c33">33</xref>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c65">65</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c66">66</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c67">67</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c68">68</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c69">69</xref>
###xml 784 790 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 65 71 <span type="species:ncbi:562">E.coli</span>
###xml 253 259 <span type="species:ncbi:562">E.coli</span>
###xml 784 790 <span type="species:ncbi:562">E.coli</span>
Currently, very little is known about repair mechanisms of dL in E.coli. Previous studies have shown that dL is a substrate for some AP endonucleases (32, and our unpublished results) and DNA glycosylases/AP lyases (33). Conversely, the repair of dR in E.coli is well studied. Various overlapping repair pathways including AP endonucleases Xth and Nfo (65), DNA glycosylases/AP lyases Fpg and Nth (66,67), the UvrABC complex, which is central in the NER pathway (68) and the RecA protein, which is central in recombination and translesion DNA synthesis (69), are involved in dR repair. In the present study, we used the M13G*1 reversion assay to explore the importance of AP endonucleases, DNA glycosylases, the NER pathway and homologous recombination in the handling of dL sites in E.coli. In addition, the repair of dR and dNi was also investigated.
###end p 35
###begin p 36
###xml 239 248 237 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT E.coli</italic>
###xml 281 283 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 320 322 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 426 433 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 679 681 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 707 709 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;5</sup>
###xml 714 723 712 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT E.coli</italic>
###xml 925 932 923 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xth nfo</italic>
###xml 1009 1011 1005 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1051 1057 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1212 1216 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">recA</italic>
###xml 1218 1225 1214 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fpg nth</italic>
###xml 1230 1234 1226 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrA</italic>
###xml 1260 1262 1256 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1375 1382 1371 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 242 248 <span type="species:ncbi:562">E.coli</span>
###xml 717 723 <span type="species:ncbi:562">E.coli</span>
###xml 1051 1057 <span type="species:ncbi:562">E.coli</span>
Under the illumination conditions used, >/=90% of dNi was converted into dL. Importantly, the UV irradiation of non-modified M13*G1 did not induce mutations. The mutation frequencies for the site-specifically incorporated dL nucleoside in WT E.coli strains were low [(5.5-5.7) x 10-5] compared with mismatched dC (4 x 10-1). The presence of dL in the (-) strand may lead to replication bias towards non-damaged (+) DNA strand in vivo and therefore mask the mutagenic effect of the lesion. However, using altered site mutagenesis we have shown that replication bias towards non-damaged (+) strand was not significant. Interestingly, the mutation frequencies for dR [(3.0-6.4) x 10-5] and dNi [(14.0-2.2) x 10-5] in WT E.coli strains were also low, suggesting that these modified residues are not highly mutagenic. However, low mutagenesis could also be due to efficient repair of dR, dL and dNi. Indeed, we showed that in the xth nfo strain the dL-induced mutation frequency increased >/=30-fold compared with WT. This result strongly suggests that in E.coli the AP endonucleases play a major role in the removal of dL. In contrast, either slight or no increase in dL-induced reversion frequency were observed in recA, fpg nth and uvrA strains as compared with WT strain suggesting that the oxidized AP sites are not substrates for AP lyases, homologous recombination and NER in vivo.
###end p 36
###begin p 37
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 134 141 134 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c65">65</xref>
###xml 244 258 244 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli xth nfo</italic>
###xml 415 423 415 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 506 508 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c66">66</xref>
###xml 509 511 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c67">67</xref>
###xml 583 586 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fpg</italic>
###xml 591 594 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nth</italic>
###xml 613 616 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xth</italic>
###xml 621 628 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xth nfo</italic>
###xml 765 772 762 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 774 776 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c70">70</xref>
###xml 777 779 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c71">71</xref>
###xml 873 887 870 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli fpg nth</italic>
###xml 976 983 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1011 1017 1008 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1096 1098 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c72">72</xref>
###xml 1306 1314 1303 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1350 1352 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c73">73</xref>
###xml 1515 1517 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c74">74</xref>
###xml 1584 1595 1581 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli recA</italic>
###xml 26 32 <span type="species:ncbi:562">E.coli</span>
###xml 244 250 <span type="species:ncbi:562">E.coli</span>
###xml 873 879 <span type="species:ncbi:562">E.coli</span>
###xml 1011 1017 <span type="species:ncbi:562">E.coli</span>
###xml 1584 1590 <span type="species:ncbi:562">E.coli</span>
AP endonuclease deficient E.coli strain has a weak spontaneous mutator phenotype suggesting that dR residues are not highly mutagenic in vivo (65). In agreement with this observation, we found only a 3-fold increase of dR-induced reversions in E.coli xth nfo mutant. This is at variance with the 30-fold increase observed with dL, implying that the oxidized AP site might be more mutagenic than dR if not repaired. In vitro the Fpg and Nth proteins can cleave dR via beta-elimination with high efficiency (66,67) and may participate in repair of AP sites. However, it was shown that fpg and nth, in contrast with xth and xth nfo mutants, are not sensitive to alkylation DNA damage, suggesting that DNA glycosylases/AP lyases play a minor role in repair of AP sites in vivo (70,71). Interestingly, we found a significant 5-fold increase of dR-induced reversion frequency in E.coli fpg nth mutant, suggesting that the DNA glycosylases/AP lyases suppress mutations induced by dR in vivo. It was also shown that in E.coli, AP site-directed mutagenesis requires activation of the SOS response system (72). This damage-inducible pathway involves the RecA-dependent induction of the error-prone DNA polymerases that lack exonuclease proofreading ability. Such polymerases are more capable of bypassing an AP site in vitro than polymerases of high fidelity (73). However, it has recently been shown that RecA also participates in error-free recombinational repair which predominates over mutagenic translesion replication (74). We found a 4-fold increase of dR-induced reversion frequency in E.coli recA mutant, suggesting that in non-induced cells RecA participates in error-free repair of dR residues.
###end p 37
###begin p 38
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 237 246 237 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT E.coli</italic>
###xml 560 571 560 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli recA</italic>
###xml 86 92 <span type="species:ncbi:562">E.coli</span>
###xml 240 246 <span type="species:ncbi:562">E.coli</span>
###xml 560 566 <span type="species:ncbi:562">E.coli</span>
Since dNi is a non-natural nucleoside, it may not be recognized by excision repair in E.coli. Indeed, no significant increase in dNi-induced mutation frequencies was observed in BER-deficient mutants compared with isogenic corresponding WT E.coli strains. Because of the very low yield of transformants in BH430 strain, nothing can be said about the role of NER in dNi-induced mutagenesis. However, we speculate that replication of dNi-containing phage may depend on NER function. Similarly to dR, a 10-fold increase in dNi-induced reversion rate was found in E.coli recA mutant, suggesting that RecA may participate either in non-mutagenic DNA translesion synthesis (TLS) or in the removal of dNi.
###end p 38
###begin p 39
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c47">47</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c48">48</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh622tb5">5</xref>
The mutagenic consequences of replicating M13 DNA containing dL, dR or dNi nucleotides were examined. Despite structural similarity between dL and dR, the 'A rule' (47,48) was not respected for either dL or dNi. We detected preferential incorporation of TMP opposite to dL, whereas TMP and dAMP were incorporated with the same insertion frequency opposite to dNi. Furthermore, in addition to base substitution, dL and dNi induced complex mutations which were combinations of deletion and insertion. Importantly, the presence of residual dNi in irradiated phage DNA cannot be considered to have a significant contribution to the dL-induced mutation spectrum. As shown in Table 5, the 'complex mutations' for these two lesions show a completely different distribution. They represent 13% of the total for dNi in 76 sequenced clones versus 4% for dL in 84 sequenced clones. Both dL and dNi preferentially induce X-->A base substitution and complex mutations, implying that translesional synthesis machinery does not discriminate these structurally different lesions efficiently. On the other hand, AP endonucleases recognize dL but not dNi. A structural study by high-field NMR spectroscopy is in progress to determine the geometry of dNi pairing with natural bases.
###end p 39
###begin p 40
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c51">51</xref>
###xml 202 209 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 332 340 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c75">75</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c77">77</xref>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 665 673 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c78">78</xref>
###xml 1073 1079 1073 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1266 1268 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c73">73</xref>
###xml 1414 1420 1414 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1572 1574 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c33">33</xref>
###xml 1575 1577 1572 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh622c79">79</xref>
###xml 1073 1079 <span type="species:ncbi:562">E.coli</span>
###xml 1414 1420 <span type="species:ncbi:562">E.coli</span>
###xml 1429 1434 <span type="species:ncbi:9606">human</span>
Previously, we demonstrated a neat preferential incorporation of dAMP opposite dL and dNi in vitro: by Klenow fragment DNA polymerase I devoid of 3' exonucleolytic activity (KF exo-) (51). In contrast, in vivo we have found preferential incorporation of TMP opposite to dL and dNi. We propose that discrepancies between in vivo and in vitro mutagenesis might be due to several factors: First, it was shown that the chemical structure of a lesion is not the only determinant of the spectra and efficiency of mutagenesis (75-77). Indeed, the neighboring sequences used for in vitro studies (5'-AXG-3') and in the present work (5'-GXA-3') were different. Importantly, in vitro replication performed on short pieces of DNA may give rise in some cases to sequence-dependent results due to a realignment process in the primer-matrix duplex. Secondly, the nature of DNA polymerases involved in TLS may influence mutational spectra. It has been postulated that in eukaryotes TLS is a 'two-polymerase affair' involving an 'inserter polymerase' and an 'extender polymerase' (78). In E.coli, polymerase V could relieve a stalled polymerase III holoenzyme at the lesion site and extend primer 3' ends, suggesting that prokaryotic TLS might be also catalyzed by two polymerases (73). Thirdly, the interactions between lesion and cellular proteins might affect TLS. Recently it has been demonstrated that dL may cross-link with E.coli Nth and human polymerase beta, indicating that dL reactivity towards cellular proteins may have also important consequences on repair and mutagenesis (33,79).
###end p 40
###begin p 41
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrA</italic>
###xml 112 118 <span type="species:ncbi:562">E.coli</span>
In conclusion, in the present study, we have demonstrated that dL is as mutagenic as the AP site in non-induced E.coli. Despite their structural analogy, repair pathways for dL and dR are not similar. In vivo the dL lesion is processed by the AP endonucleases Xth and Nfo which are involved in abasic lesion repair. Unlike dR, the dL residue is a rather poor substrate for Fpg, Nth and recombinational repair. The absence of an increase of mutagenesis in uvrA mutant strongly suggests that dL is not a substrate for NER pathway. Finally, the most common mutagenic response to the presence of dL is the incorporation of TMP. These results show that a small difference in the DNA lesion structure can have tremendous effect on repair and mutagenesis.
###end p 41
###begin title 42
Figures and Tables
###end title 42
###begin p 43
 Structure of the abasic lesions dL (2'-deoxyribonolactone) and dR (2'-deoxyribose) and of dNi (nitroindole precursor).
###end p 43
###begin p 44
 Analysis of the 41mer oligonucleotides containing dU, dR, dNi and dL lesions by denaturing PAGE. Lanes 1,4,7 and 10, 300 nM NaOH for 30 min at 37degreesC; lanes 2,5 and 8, non-treated oligonucleotides; lanes 3,6 and 9, 100 nM Nfo for 10 min at 37degreesC. For details see Materials and Methods.
###end p 44
###begin title 45
Bacterial strains
###end title 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fpg</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xth</italic>
aThe insertions X::Tn10 are the co-transducible tetracycline resistance markers with fpg or xth.
###end p 46
###begin title 47
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Mutation frequencies from in vivo replication of site-specifically incorporated dL residue into M13G*1 phage DNA
###end title 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aFrequency numbers are the average +/- standard deviation of three to five independent experiments.
###end p 48
###begin title 49
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Mutation frequencies from in vivo replication of site-specifically incorporated dR residue into M13G*1 phage DNA
###end title 49
###begin p 50
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aFrequency numbers are the average +/- standard deviation of three to five independent experiments.
###end p 50
###begin title 51
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Mutation frequencies from in vivo replication of site-specifically incorporated dNi residue into M13G*1 phage DNA
###end title 51
###begin p 52
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aFrequency numbers are the average +/- standard deviation of three to five independent experiments.
###end p 52
###begin title 53
Mutation spectra of the site-specifically incorporated lesions
###end title 53
###begin title 54
ACKNOWLEDGEMENTS
###end title 54
###begin p 55
We thank Dr Jacques Laval for his interest in this work. We wish to thank Dr Thomas Reid and Dr Lawrence A. Loeb for the M13G*1 bacteriophage vector, Dr Mitsuaru Kotera for the dNi phosphoramidite and Elisabeth Loire for technical assistance. We also thank Professor Marc Greenberg for sharing results prior to publication. This research was supported by European Community Grant RISC-RAD FI6R-CT-2003-508842 (M.S.), Association pour la Recherche sur le Cancer (M.S.) and Electricite de France Contrat Radioprotection RB 2004-02 (M.S.) and RB 2003-28 (J.-F.C and P.D.).
###end p 55
###begin title 56
REFERENCES
###end title 56

